Florida · 2025 Regular Session · Bill
SB 876: Chimeric Antigen Receptor T-cell Therapy
Did not advance Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
- Did not advance
Last official action: ·Record last updated:
Plain-language summary
SB 876 is a bill introduced in the Florida Senate on February 19, 2025. According to its official title, it concerns: Chimeric Antigen Receptor T-cell Therapy. Primary sponsor: Lori Berman (Democratic). Most recent recorded action (June 16, 2025): Died in Banking and Insurance.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Chimeric Antigen Receptor T-cell Therapy; Prohibiting health insurers and health maintenance organizations issuing, delivering, or renewing certain policies or contracts from refusing to contract with or denying coverage for certain providers of chimeric antigen receptor T-cell therapy, etc.
Sponsors
Sponsors by party (alphabetical): Democratic 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Lori Berman | Primary sponsor | Democratic | Senate | 26 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Died in Banking and Insurance
- Indefinitely postponed and withdrawn from consideration
- Introduced
- Referred to Banking and Insurance; Judiciary; Rules
- Filed